CYBG vs. EAT, HKLB, and SWEF
Should you be buying VanEck Bionic Engineering UCITS ETF A Acc stock or one of its competitors? The main competitors of VanEck Bionic Engineering UCITS ETF A Acc include European Assets Trust (EAT), Hongkong Land (HKLB), and Starwood European Real Estate Finance (SWEF). These companies are all part of the "finance" sector.
European Assets Trust (LON:EAT) and VanEck Bionic Engineering UCITS ETF A Acc (LON:CYBG) are both small-cap finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, community ranking, media sentiment, analyst recommendations, dividends, profitability, valuation, risk and earnings.
European Assets Trust has a net margin of 87.48% compared to European Assets Trust's net margin of 0.00%. VanEck Bionic Engineering UCITS ETF A Acc's return on equity of 8.72% beat European Assets Trust's return on equity.
European Assets Trust pays an annual dividend of GBX 6 per share and has a dividend yield of 6.9%. VanEck Bionic Engineering UCITS ETF A Acc pays an annual dividend of GBX 0.03 per share and has a dividend yield of 0.2%. European Assets Trust pays out 6,666.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. VanEck Bionic Engineering UCITS ETF A Acc pays out -0.4% of its earnings in the form of a dividend.
40.3% of European Assets Trust shares are owned by institutional investors. 0.8% of European Assets Trust shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
In the previous week, European Assets Trust had 2 more articles in the media than VanEck Bionic Engineering UCITS ETF A Acc. MarketBeat recorded 3 mentions for European Assets Trust and 1 mentions for VanEck Bionic Engineering UCITS ETF A Acc. European Assets Trust's average media sentiment score of 0.67 beat VanEck Bionic Engineering UCITS ETF A Acc's score of 0.33 indicating that VanEck Bionic Engineering UCITS ETF A Acc is being referred to more favorably in the news media.
European Assets Trust has higher earnings, but lower revenue than VanEck Bionic Engineering UCITS ETF A Acc. VanEck Bionic Engineering UCITS ETF A Acc is trading at a lower price-to-earnings ratio than European Assets Trust, indicating that it is currently the more affordable of the two stocks.
European Assets Trust currently has a consensus target price of GBX 1,437, indicating a potential upside of 1,551.72%. Given VanEck Bionic Engineering UCITS ETF A Acc's higher possible upside, research analysts plainly believe European Assets Trust is more favorable than VanEck Bionic Engineering UCITS ETF A Acc.
VanEck Bionic Engineering UCITS ETF A Acc received 93 more outperform votes than European Assets Trust when rated by MarketBeat users. However, 65.09% of users gave European Assets Trust an outperform vote while only 50.88% of users gave VanEck Bionic Engineering UCITS ETF A Acc an outperform vote.
Summary
European Assets Trust beats VanEck Bionic Engineering UCITS ETF A Acc on 12 of the 16 factors compared between the two stocks.
Get VanEck Bionic Engineering UCITS ETF A Acc News Delivered to You Automatically
Sign up to receive the latest news and ratings for CYBG and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CYBG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
VanEck Bionic Engineering UCITS ETF A Acc Competitors List
Related Companies and Tools
